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Alpha-fetoprotein in chronic hepatitis CWe read with great interest the article in the Journal of the
Formosan Medical Society by Tai et al,1 reporting a retro-
spective study of 654 patients with chronic hepatitis C (CHC)
and no evidence of hepatocellular carcinoma (HCC) (as
judged from imaging studies at enrolment), in which they
examined the association of an elevated alpha-fetoprotein
(AFP) concentration with CHC. In multivariate analyses, the
authors identified age, histological activity index (HAI)
inflammation score, serum alanine aminotransferase (ALT),
and platelet count as significant correlates of elevated AFP
concentration, and hepatitis C virus (HCV) genotype 1b,
platelet count, aspartate aminotransferase (AST), and AFP
concentration, as significant correlates of advanced liver
fibrosis. These findings are interesting and provide additional
information to this area of active investigation, but several
issues deserve further discussion.
First, insulin resistance and metabolic derangements
have been linked to severity of liver histology, such as
hepatic steatosis, fibrosis progression and HCC.2e5 In addi-
tion, age, sex, obesity, alcohol consumption, diabetes
mellitus and hyperlipidemia, and the medication history,
may affect host metabolism6,7 and lead to liver fibrosis
progression in CHC patients. Therefore, it would be more
informative if the authors could provide information
regarding metabolic factors in their patients.
Second, as elevation of the AFP concentration is iden-
tified as an important predictor for liver fibrosis in this
study, it remains unclear whether metabolic factors may
also contribute to this elevation. Prospective large-scale
studies with complete data are required to examine the
complex relationships between clinical variables, AFP
concentratio and liver fibrosis.
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